Skip to main content
573 Micronutrient imbalances and body composition in pediatric cystic fibrosis in the era of CFTR modulator therapy.
570 Evaluating BMI and body composition in cystic fibrosis patients to optimize nutritional strategies.
336 Zinc inhibits CFTR in the intestinal epithelia via activating calcium- sensing receptor (CaSR).
613 Assessing the prevalence of hepatobiliary involvement in cystic fibrosis using European Society for Paediatric Gastroenterology Hepatology and Nutrition and North American Society For Pediatric Gastroenterology, Hepatology and Nutrition classification
610 Gaps between new hepatobiliary screening guidelines and clinical practice in cystic fibrosis.
109 Chemical development of dual species–host and Aspergillus fumigatus–sphingosine-1-phosphate lyase inhibitors as therapeutic strategy in cystic fibrosis.
813 Decreasing sweat chloride quantity not sufficient rates.
148 Exploring dual targeting of host and microbial sphingosine-1-phosphate lyase as antimicrobial strategy in cystic fibrosis.
483 Describing the oropharyngeal microbiome in children with cystic fibrosis transmembrane regulator related metabolic syndrome.
77 Improving transition from pediatric to adult cystic fibrosis care: A quality improvement initiative.